Clinical Trial Diversity: US FDA’s Califf Calls For Global Focus

 
• By Michael McCaughan

Commissioner Robert Califf urged a change in clinical trial diversity discussions, emphasizing the need to consider the realities of US leadership in a global drug development ecosystem.

diversity
Robert Califf argues clinical trial diversity efforts should consider the global population. • Source: Shutterstock

More from Clinical Trials

More from R&D